Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Carpenter Technology Corporation Announces Proposed $700.0 Million Private Offering of Senior Notes Due 2034
-
Applied Digital Announces Proposed Offering of $2.35 Billion of Senior Secured Notes
-
Antalpha Reports Third Quarter 2025 Results
-
Surgery Partners, Inc. Announces Third Quarter 2025 Results
-
Tyson Foods Reports Fourth Quarter And Fiscal 2025 Results
-
FreightCar America, Inc. Reports Third Quarter 2025 Results
-
Bluejay Therapeutics’ Brelovitug (BJT-778) Monotherapy Achieved 100% Virologic Response and up to 82% Combined Endpoint of Virologic Response and ALT Normalization at Week 48 in Phase 2 Study in Chr
-
OneMedNet Delivers on Revenue Model Promise with Palantir-Powered RWD Subscriptions: Live Feeds & AI Search
-
FG Nexus to Present at the 2025 Cantor Crypto & AI/Energy Infrastructure Conference
-
Cytokinetics Presents Additional Data from MAPLE-HCM at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions and American Heart Association Scientific Sessions 2025
-
IMUNON R&D Day Showcases Clinical Progress of Its Novel Immunotherapy, Phase 3 Trial and Significant Potential for Women with Ovarian Cancer
-
Bluejay Diagnostics Corporate Update: Advancing Clinical Milestones and Strategic Partnerships
-
InflaRx Reports Positive Phase 2a Data for INF904 in Hidradenitis Suppurative (HS) and Chronic Spontaneous Urticaria (CSU)
-
Bakkt Reports Third Quarter 2025 Results
-
OneMedNet Delivers on Revenue Model Promise with Palantir-Powered RWD Subscriptions: Live Feeds & AI Search
-
Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update
-
SUNation Energy Announces 2025 Third Quarter Results and Reiterates 2025 Full Year Financial Guidance
-
Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer
-
FG Nexus to Present at the 2025 Cantor Crypto & AI/Energy Infrastructure Conference
-
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
-
IMUNON R&D Day Showcases Clinical Progress of Its Novel Immunotherapy, Phase 3 Trial and Significant Potential for Women with Ovarian Cancer
-
Bicara Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
-
Matador Technologies Inc. Announces Closing of Convertible Note Facility to Expand Bitcoin Holdings
-
Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin Treatments
-
Vera Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
-
Vera Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
-
Alterity Therapeutics Presents Promising Impact of ATH434 on Orthostatic Hypotension and Disease Progression in MSA at the 36th International Symposium on the Autonomic Nervous System
-
Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
-
Prenetics Reports Record Third Quarter 2025 Results; IM8 on Track for $120M ARR¹ by December 2025, Fastest Supplement Brand Growth in Industry History
-
Wenlay Releases Cross-Chain Bridge Solution to Tackle Multi-Chain Liquidity Challenges
-
Exodus Movement, Inc. Announces Acquisition of Grateful To Strengthen Stablecoin-Based Payments
-
Alpha Modus Secures Patent License and Expands AI-Retail Ecosystem Through New Authorized Reseller Agreement
-
AirBoss Defense Group Received Order CBRN Products Valued at $8.1M
-
Genmab Announces Proposed Private Offering of Senior Secured Notes and Senior Unsecured Notes and Syndication of New Senior Secured Term Loan Facility
-
Same-Day Loans with Guaranteed Approval and No Credit Check for Bad Credit Borrowers: Introduced by RadCred for Debt Relief
-
Apogee Therapeutics Provides Pipeline Progress and Reports Third Quarter 2025 Financial Results
-
uniQure Announces Third Quarter 2025 Financial Results and Provides Corporate Update
-
Outdoor Holding Company Reports Positive Net Income from Continuing Operations for Second Quarter Fiscal 2026
-
VALLOUREC ANNOUNCES EXPANSION OF YOUNGSTOWN MANUFACTURING OPERATIONS
-
Cielo Announces Closing of First Tranche of Unit Offering
-
MAX Power Brings Together Leading Natural Hydrogen Experts for Technical Collaboration and Drill Site Visit
-
Kaspi.kz 3Q & 9M 2025 Financial Results
-
Orbus Therapeutics Announces Oral Presentation of Updated Results With Blinded Independent Central Review from the Phase 3 STELLAR Clinical Trial at the Society for Neuro-Oncology Annual Meeting
-
Enviri Corporation Reports Third Quarter 2025 Results
-
Zacatecas Silver Secures Community Access Agreement at Panuco and Signs Drill Contract with Major Drilling
-
Norwegian Cruise Line Holdings Confirms Newbuild Order for Third Prestige-Class Ship for Regent Seven Seas Cruises
-
ONL Therapeutics to Present at EYENOVATE and the FLORetina–ICOOR Congress 2025
-
Immunovant Provides Corporate Updates and Reports Financial Results for the Second Quarter Ended September 30, 2025
-
Anfield Energy Welcomes U.S. Designation of Uranium as Critical Mineral, Unlocking Funding and Accelerated Development for Domestic Projects
-
Apogee Therapeutics Announces Positive Interim Phase 1 Results from Healthy Volunteer Trial of APG333, its Novel Half-Life Extended TSLP Antibody
